Sacchetti Federico, Alsina Andac Celasun, Morganti Riccardo, Innocenti Matteo, Andreani Lorenzo, Muratori Francesco, Scoccianti Guido, Totti Francesca, Campanacci Domenico Andrea, Capanna Rodolfo
Department of Orthopaedic and Trauma Surgery, University of Pisa, Italy.
Department of Orthopaedic and Trauma Surgery, Ege University, Izmir, Turkey.
J Orthop. 2021 May 14;25:244-251. doi: 10.1016/j.jor.2021.05.022. eCollection 2021 May-Jun.
In Soft Tissue Sarcomas (STS) referral centre many patients have already had an incomplete tumour resection. In the majority of specimen, tumoral residual is detected and linked to a worsen prognosis. Systematic surgical re-resection of the scar tissue area is often performed. Some authors suggested to postpone re-resections until a clinically evident local recurrence is detected. A searching strategy was applied to Pubmed-Central and Ovid Medline. Odds ratio (OR) for local recurrence (LR), distant metastasis (MTS) or overall survival (OS) were calculated comparing patients who had tumour residual to people who hadn't. OR of local recurrences, distant metastasis and OS were calculated in planned vs unplanned-excisions groups. OR to develop a metastasis and OS after a local recurrences were calculated. Residual tumour led to an OR for LR of 3,56, OR of MTS was 3,42; OR of decreased OS was 3,42. Having a LR lead to a OR of 1,55 for MTS and to a OR of decreased OS of 2,32. Patients who underwent a re-excision compared to planned surgery did not have an increased OR of LR and had an OR to develop a MTS of 0,56. Our data confirm that there is a strong correlation between local recurrences, distant relapses and overall survival. Although there is a selection bias; this analysis highlights the optimal oncological outcome in patients who underwent re-resection. The rationale for systematic re-resection after unplanned excision of soft tissue sarcomas is very strong and this treatment remains the gold standard of care in these patients.
在软组织肉瘤(STS)转诊中心,许多患者已经接受了不完全的肿瘤切除。在大多数标本中,可检测到肿瘤残留,且这与预后恶化相关。通常会对瘢痕组织区域进行系统性手术再次切除。一些作者建议将再次切除推迟到检测到临床明显的局部复发时进行。我们对PubMed-Central和Ovid Medline应用了检索策略。比较有肿瘤残留的患者和无肿瘤残留的患者,计算局部复发(LR)、远处转移(MTS)或总生存期(OS)的比值比(OR)。在计划切除组与非计划切除组中计算局部复发、远处转移和OS的OR。计算局部复发后发生转移和OS的OR。残留肿瘤导致LR的OR为3.56,MTS的OR为3.42;OS降低的OR为3.42。发生LR导致MTS的OR为1.55,OS降低的OR为2.32。与计划手术相比,接受再次切除的患者LR的OR没有增加,发生MTS的OR为0.56。我们的数据证实局部复发、远处复发和总生存期之间存在很强的相关性。尽管存在选择偏倚;但该分析突出了接受再次切除的患者的最佳肿瘤学结局。软组织肉瘤非计划切除后进行系统性再次切除的理论依据非常充分,这种治疗仍然是这些患者的护理金标准。